Insider buying
~$244K1,600 sh @ $152.25
Their first buy on recordTraded Nov 10 · filed 2 days later
Since the trade −5.2% · S&P 500 −8.0% · to Nov 20
Bought at the 52-week low, RSI 21, 46% under its 200-day average, 29 points behind the S&P 500 over 3 months
An Alnylam Pharmaceuticals director paid $244K out of pocket for Alnylam Pharmaceuticals shares. 1 other person at Alnylam Pharmaceuticals bought some too, in the same month. It was the first purchase in over a year.